The measurement of maternal plasma corticotropin-releasing factor (CRF) and CRF-binding protein improves the early prediction of preeclampsia

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4673-4677

  Florio, P ^a   Imperatore, A ^a   Sanseverino, F ^a   Torricelli, M ^a   Reis, F M ^a   Lowry, P J ^b   Petraglia, F ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMICAL MARKER; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN; HORMONE BINDING PROTEIN; NEUROHORMONE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GESTATIONAL AGE; HIGH RISK PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MATERNAL PLASMA; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; ROC CURVE; STATISTICAL SIGNIFICANCE; THIRD TRIMESTER PREGNANCY;

ADULT; CARRIER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PROBABILITY; PROSPECTIVE STUDIES;

EID: 4544382136     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0186     Document Type: Article

References (27)

1. Roberts JM, Cooper DW 2001 Pathogenesis and genetics of pre-eclampsia. Lancet 357:53-56
2. Reis FM, D'Antona D, Petraglia F 2002 Predictive value of hormone measurements in maternal and fetal complications of pregnancy. Endocr Rev 23:230-257
3. Page NM, Kemp CF, Butlin DJ, Lowry PJ 2002 Placental peptides as markers of gestational disease. Reproduction 123:487-495
4. Florio P, Severi FM, Ciarmela P, Fiore G, Calonaci G, Merola A, De Felice C, Palumbo M, Petraglia F 2002 Placental stress factors and maternal-fetal adaptive response: the corticotropin-releasing factor family. Endocrine 19:91-102
5. Petraglia F, Florio P, Benedetto C, Gallo C, Woods RJ, Genazzani AR, Lowry PJ 1996 High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension. J Clin Endocrinol Metab 81:852-856
6. Petraglia F, Potter E, Cameron VA, Sutton S, Behan DP, Woods RJ, Sawchenko PE, Lowry PJ, Vale W1993 Corticotropin-releasing factor-binding protein is produced by human placenta and intrauterine tissues. J Clin Endocrinol Metab 77:919-924
7. Potter E, Behan DP, Fischer WH, Linton EA, Lowry PJ, Vale WW 1991 Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 349:423-426
8. Petraglia F, Florio P, Gallo R, Salvestroni C, Lombarde M, Genazzani AD, Di Carlo C, Stomati M, D'Ambrogio G, Artini PG 1996 Corticotropin-releasing factor-binding protein: origins and possible functions. Horm Res 45:187-191
9. National High Blood Pressure Education Program 2000 Report of the National High Blood Pressure Education Program Working Group on high blood pressure in pregnancy. Am J Obstet Gynecol 183:51-322
10. Woods RJ, Grossman A, Saphier P, Kennedy K, Ur E, Behan D, Potter E, Vale W, Lowry PJ 1994 Association of human corticotropin-releasing hormone to its binding protein in blood may trigger clearance of the complex. J Clin Endocrinol Metab 78:73-76
11. Stephan C, Wesseling S, Schink T, Jung K 2003 Comparison of eight computer programs for receiver-operating characteristic analysis. Clin Chem 49:433-439
12. Zweig MH, Campbell G 1993 Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 39:561-577
13. Richardson WS, Wilson MC, Guyatt GH, Cook DJ, Nishikawa J 1999 Users' guides to the medical literature. XV. How to use an article about disease probability for differencial diagnosis. Evidence-based medicine working group. JAMA 281:1214-1219
14. Clifton VL, Crompton R, Smith R, Wright IM 2002 Microvascular effects of CRH in human skin vary in relation to gender. J Clin Endocrinol Metab 87:267-270
15. Lei S, Richter R, Bienert M, Mulvany MJ 1993 Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol 108:941-947
16. Jain V, Vedernikov YP, Saade GR, Chwalisz K, Garfield RE 1999 Endothelium-dependent and -independent mechanisms of vasorelaxation by corticotropin-releasing factor in pregnant rat uterine artery. J Pharmacol Exp Ther 288:407-413
17. Leitch IM, Boura AL, Botti C, Read MA, Walters WA, Smith R 1998 Vasodilator actions of urocortin and related peptides in the human perfused placenta in vitro. J Clin Endocrinol Metab 83:4510-4513
18. Simoncini T, Apa R, Reis FM, Miceli F, Stomati M, Driul L, Lanzone A, Genazzani AR, Petraglia F 1999 Human umbilical vein endothelial cells: a new source and potential target for corticotropin-releasing factor. J Clin Endocrinol Metab 84:2802-2806
19. Jain V, Longo M, Ali M, Saade GR, Chwalisz K, Garfield RE 2000 Expression of receptors for corticotropin-releasing factor in the vasculature of pregnant rats. J Soc Gynecol Invest 7:153-160
20. Cantarella G, Lempereur L, Lombardo G, Chiarenza A, Pafumi C, Zappala G, Bernardini R 2001 Divergent effects of corticotropin releasing hormone on endothelial cell nitric oxide synthase are associated with different expression of CRH type 1 and 2 receptors. Br J Pharmacol 134:837-844
21. Campbell EA, Linton EA, Wolfe CDA, Scraggs PR, Jones MT, Lowry PJ 1987 Plasma corticotropin-releasing hormone concentrations during pregnancy and parturition. J Clin Endocrinol Metab 64:1054-1059
22. Poston L, McCarthy AL, Ritter JM 1995 Control of vascular resistance in the maternal and feto-placental arterial beds. Pharmacol Ther 65:215-239
23. Sibai BM 1996 Hypertension in pregnancy In: Gabbe SG, Niebyl JR, Simpson JL, eds. Obstetrics: normal and problem pregnancies. New York: Churchill Livingstone; 935-996
24. Dekker G, Sibai B 2001 Primary, secondary, and ternary prevention of preeclampsia. Lancet 357:209-201
25. Boura AL, Walters WA, Read MA, Leitch IM 1994 Autacoids and control of human placental blood flow. Clin Exp Pharmacol Physiol 21:737-748
26. Clifton VL, Read MA, Leitch IM, Boura AL, Robinson PJ, Smith R 1994 Corticotropin-releasing hormone-induced vasodilatation in the human fetal placental circulation. J Clin Endocrinol Metab 79:666-669
27. Clifton VL, Read MA, Leitch IM, Giles WB, Boura AL, Robinson PJ, Smith R 1995 Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3′,5′-monophosphate-mediated pathway. J Clin Endocrinol Metab 80:2888-2893